and Human Services (HHS)
EXPIRED
Department of Health and Human Services
Participating Organizations
National Institutes of Health (NIH), (http://www.nih.gov/)
Components of
Participating Organizations
National Cancer Institute (NCI) (http://www.nci.nih.gov/)
National Institute on Aging (NIA) (http://www.nia.nih.gov/)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov/)
National Center for Complementary and Alternative Medicine (NCCAM) (http://www.nccam.nih.gov/)
Office of Dietary Supplements (ODS), (http://ods.od.nih.gov)
Title: Academic Career Award (K07)
Announcement
Type
This is a reissue of PA-00-070 .
Update: The following update relating to this announcement has been issued:
Looking ahead: As part of the Department of Health and Human Services' implementation of e-Government the NIH will gradually transition each grant mechanism to electronic submission through Grants.gov and the use of the SF 424 Research and Related (R&R) forms. For more information and an initial timeline, seehttp://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-035.html. NIH will announce each grant mechanism change in the NIH Guide to Grants and Contracts (http://grants.nih.gov/grants/guide/index.html).
Program Announcement (PA) Number: PA-08-152
Catalog of Federal Domestic Assistance Number(s):
93.392, 93.866, 93.272, 93.213
Key Dates
Release Date: April 18, 2008
Letters of Intent Submission Date(s): Not applicable
Application Submission Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
AIDS Application Submission Date(s): http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS
Peer Review Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
Council Review Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
Earliest Anticipated Start Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
Additional Information To Be Available (URL Activation Date):
Not applicable
Expiration Date:
January 8, 2009 (per PA-09-041) -
Originally: May 8, 2011
Due Dates for E.O. 12372
Not Applicable
Executive Summary
The goals of NIH-supported career development programs are to help ensure that diverse pools of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation's biomedical, behavioral, and clinical research needs.
Table of Contents
Part I Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Career Objectives
Section II. Award Information
1. Mechanism of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section IV. Application and Submission and Instructions
1. Address to Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Submission, Review and Anticipated Start Dates
1. Letter of Intent
B. Sending an Application to the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements and Information
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Resource Sharing Plan(s)
3. Anticipated Announcement and Award Dates
Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section VII. Agency Contacts
1. Scientific/Research Contacts
2. Peer Review Contacts
3. Financial/ Grants Management Contacts
Section VIII. Other Information - Required Federal Citations
Part
II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Career Objectives
The objectives of the NIH Academic Career Award (K07) are to increase the pool of individuals with academic and research expertise in a specific area of biomedical research and to enhance the educational or research capacity at the grantee institution. This funding opportunity announcement (FOA) provides support for either of two types of activities:
See Section
VIII, Other Information - Required Federal Citations, for policies related
to this announcement.
Section II. Award
Information
1. Mechanism of Support
This FOA will use the NIH K07 award mechanism. As an
applicant you will be solely responsible for planning, directing, and executing
the proposed K07 program activities on behalf of the applicant institution.
Each Academic Career Program must be tailored to meet the individual needs of
the candidate.
This FOA uses the just-in-time budget concepts. It also uses the non-modular budget format described in the PHS 398 application instructions (see http://grants.nih.gov/grants/funding/phs398/phs398.html). The applicant should follow the Research Career Development Award (K-series) instructions for budget information described in the PHS 398, providing only the total direct costs requested for each year and for the entire proposed period of support, and the supporting budget justification information. A K07 award is not renewable and cannot be transferred from one PD/PI to another.
Development award: This award provides up to 5 years (a minimum of 3 years is required) of salary and research support for more junior investigators who are interested in developing academic and research expertise in a particular health-related field, as a way to increase the overall pool of individuals capable of research or teaching in the identified area. During the period of the award, the candidate will become a successful academic researcher in the chosen area. Research, teaching, and leadership skills are to be learned during the tenure of the award. Curriculum building skills are encouraged. A mentor is required. A minimum of 9 person months (75%) of full-time professional effort is required annually; the remainder may be devoted to other research related and/or teaching pursuits consonant with the objectives of the award.
Leadership award: This award provides support for up to 5 years (a minimum of 2 years is required) for more senior investigators who are interested in improving the curricula and enhancing the health-related research capacity within an academic institution. The Leadership candidate must have acknowledged scientific expertise and leadership skills and sufficient clinical training, research, or teaching experience in the academic area of interest to an NIH awarding component to implement a program of curriculum development within the sponsoring institution. It is expected that support under this award will increase the visibility and the overall research support or academic capacity for the given field of research within the academic medical/health and research community. At least 3 person months (25%) but not more than 6 person months (50%) of full-time professional effort must be devoted to the program annually.
K07 Development and Leadership awards are not renewable nor are they transferable from one PD/PI to another. Because the objectives of the K07 are to increase the pool of individuals in academia and/or to implement or enhance curriculum development within the sponsoring institution, awards are not transferable to another institution. Only in exceptional circumstances would consideration be given for the transfer of a Development award (See VI.2.E.)
2. Funds Available
Because the nature and scope of the proposed K07 program will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the sponsoring ICs provide support for this program, awards pursuant to this FOA are contingent upon quality, duration and costs of the applications received, the submission of a sufficient number of meritorious applications, the availability of funds, and the program priorities of the appropriate IC.
Awards include funds for salary, fringe benefits, and research/development support. The salary limits and research support costs are not uniform throughout the NIH and are determined independently by each awarding component. Prospective candidates should review the web-table for additional information relevant to each individual IC supporting the K07 program (Table for IC contact information).
2.A. Allowable Costs
Salary: The NIH K07 will provide salary for the Development award recipient for 9 person-months full-time professional effort (75%)conducting the research and developmental programs activities described in the application required for academic development. The NIH will provide salary for the Leadership award recipient for 3-6 person-months full-time professional effort (25% to 50%) a portion of which may include research. Note that salary limits on career awards are not uniform throughout the NIH; therefore, prospective candidates should contact the NIH component to which the application is targeted to ascertain the possible maximum salary contribution.
The salary must be consistent both with the established salary structure at the institution and with salaries actually provided by the institution from its own funds to other staff members of equivalent qualifications, rank, and responsibilities in the department concerned. If full-time, 12-month salaries are not currently paid to comparable staff members, the salary proposed must be appropriately related to the existing salary structure. Confirmation of salary is required prior to the issuance of an award. Fringe benefits, based on the sponsoring institution’s rate and the percent of effort, are provided in addition to the salary.
For information regarding NIH policy in determining full-time professional effort for career awards, see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-04-056.html. Candidates who have U.S. Veteran’s Administration (VA) appointments may not consider part of the VA effort toward satisfying the full time requirement at the applicant sponsoring institution. Candidates with VA appointments should contact the staff person in the relevant Institute prior to preparing application to discuss their eligibility.
The sponsoring institution may supplement the K07 salary contribution up to a level that is consistent with the institution’s salary scale. However, institutional supplementation of salary must not require extra duties or responsibilities that would interfere with the purpose of the award. In addition, recipients of the Development award may derive additional compensation for effort associated with other Federal sources or awards, including NIH research grants. NIH policy allows K07 recipients in the final two years of their award to receive salary support from both their K award and an NIH research grant or subproject (see NOT-OD-04-007). The K-award recipient must be the named PD/PI on a competing NIH research project grant (R01, R03, R15, R21, R34, etc.), or be the sub-project director on a competing multi-component research or center grant or cooperative agreement (P01, P50, U01, etc.). Under expanded authorities, institutions may rebudget funds within the total costs awarded to cover salaries consistent with the institution’s salary scale. The total salary, however, may not exceed the legislated maximum salary in place at the time of award (see NOT-OD-08-035).
Research Development Support: Research expenses and career development costs may be provided at the discretion of the NIH IC, and the amounts are reflected in the web-table (Table for IC contact information). Such costs may include: personnel other than the PD/PI, if required (e.g., technical staff, consultants), supplies, computer time, and travel essential for the approved program. Applicants should contact the relevant IC concerning costs items allowed for research development support.
Ancillary Personnel Support: Salary for mentors or for secretarial or administrative assistants, etc. is not allowed.
Recurring costs in future years: No yearly escalation for recurring costs will be provided.
Facilities and Administrative (F&A) Costs: F&A costs, which were formerly called indirect costs, will be reimbursed at 8% of modified total direct costs, exclusive of tuition and fees, and expenditures for equipment.
Section III. Eligibility Information
1. Eligible Applicants
1.A. Eligible
Institutions
You may submit (an) application(s) if your organization has any of the
following characteristics:
Foreign institutions are not eligible to apply.
1.B. Eligible Individuals
Any individual with the skills, knowledge, and
resources necessary to carry out the proposed activities under either the Development or Leadership aspects of
the K07 award is invited to work with their institution to develop an
application for support. Individuals from underrepresented racial and ethnic
groups, individuals with disabilities, and individuals from disadvantaged
backgrounds are further encouraged to apply for NIH support. The following
additional eligibility requirements apply:
Citizenship and Residency: Only U.S. citizens or non-citizen nationals, or individuals lawfully admitted for permanent residence who possesses an Alien Registration Receipt Card (I-151 or I-551), or some other verification of legal admission as a permanent resident prior to the time of award, are eligible for this award. Non-citizen nationals, although not U.S. citizens, owe permanent allegiance to the U.S. They are usually born in lands that are not states but are under U.S. sovereignty, jurisdiction, or administration. Individuals on temporary or student visas are not eligible.
Degree and Research: Candidates for this award must have a clinical, research, or health-professional doctoral degree or its equivalent. Such degrees include but are not limited to the Ph.D., M.D., D.O., D.D.S., D.M.D., O.D., D.C., D.S.W., D.P.H., Pharm.D., N.D. (Doctor of Naturopathy), as well as a doctoral degree in nursing research or practice.
Effort: Candidates for the Development or Leadership award must have a full-time appointment at the academic institution that is the applicant institution. Candidates who have VA appointments may not consider part of the VA effort towards satisfying the full-time requirement at the applicant institution (see: NOT-OD-04-056). Candidates with VA appointments should contact the staff person in the relevant NIH IC prior to preparing an application to discuss their eligibility (Table for IC contact information).
Renewals: The K07 award is not renewable.
2. Cost Sharing or Matching
This program does not require cost sharing as defined in the current NIH Grants
Policy Statement. The most current Grants Policy Statement can be found
at: http://grants.nih.gov/grants/policy/nihgps_2003/nihgps_Part2.htm#matching_or_cost_sharing
3. Other-Special Eligibility Criteria
Leadership award:
Key elements and common aspects that will be considered for each application include:
Section IV. Application and Submission Information
1. Address to Request Application Information
The PHS 398 application instructions are available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. Applicants must use the currently approved version of
the PHS 398. For further assistance contact Grants Info, Telephone (301)
710-0267, Email: [email protected].
Telecommunications for the hearing impaired: TTY
301-451-5936.
2. Content and Form of Application Submission
Applications must be prepared using the PHS 398 research grant application instructions and forms. Applications must have a Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at http://www.dunandbradstreet.com/. The D&B number should be entered on the face page of the PHS 398 form.
The title and number of this funding opportunity must be typed in item (box) 2 only of the face page of the application form and the YES box must be checked.
Special Note: All applications (new or revised) responding to the Development component of this announcement must include at least three sealed letters of reference (one copy each) attached to the face page of the original application. Applications submitted without the required number of reference letters will be considered incomplete and the application will not be reviewed. Information for reference submissions is included in the application instructions.
3. Submission Dates and Times
3.A. Submission, Review and Anticipated Start Dates
Letters
of Intent Submission Date(s): Not applicable.
Application Submission Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
AIDS Application Submission Date(s): http://grants1.nih.gov/grants/funding/submissionschedule.htm#AIDS Peer Review Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
Council Review Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
Earliest Anticipated Start Date(s): http://grants.nih.gov/grants/funding/submissionschedule.htm
3.A.1. Letter of
Intent
A letter of intent is not required for this funding opportunity.
3.B. Sending an Application to the NIH
Applications must be prepared using the PHS 398 research grant application
instructions including the additional K series instructions and forms as
described above. Submit a signed, typewritten original of the application,
including the checklist, and five signed photocopies in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)
Personal deliveries of applications are no longer
permitted (see NOT-OD-03-040).
3.C. Application Processing
Applications must be submitted on or before the application receipt/submission dates described above (Section IV.3.A.) and at http://grants.nih.gov/grants/dates.htm. Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review (CSR). Incomplete applications will not be reviewed.
The NIH will not accept any application in response to this funding opportunity that is essentially the same as one currently pending initial merit review unless the applicant withdraws the pending application. The NIH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of a substantial revision of an application already reviewed, but such application must include an Introduction addressing the previous critique.
Information on the status of an application should be
checked by the PD/PI in the NIH eRA Commons at: https://commons.era.nih.gov/commons/.
4.
Intergovernmental Review
This initiative is not subject to intergovernmental review.
5. Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and
other considerations described in the NIH Grants
Policy Statement
Citizenship: Applicants must meet the citizenship
requirements as described in the Eligibility section of this announcement prior
to award (Section
III).
Concurrent Awards: Applicant must be aware of the NIH policies associated with other federally sponsored support.
Pre-Award
Costs: Pre-award
costs are allowable. A grantee may, at its own risk and without NIH prior
approval, incur obligations and expenditures to cover costs up to 90 days
before the beginning date of the initial budget period of a new award if such
costs are necessary to conduct the project, and would be allowable under the
grant, if awarded, without NIH prior approval. If specific expenditures would
otherwise require prior approval, the grantee must obtain NIH approval before
incurring the cost. NIH prior approval is required for any costs to be
incurred more than 90 days before the beginning date of the initial budget period
of a new award.
The incurrence of pre-award costs in anticipation of a
competing or non-competing award imposes no obligation on NIH either to make
the award or to increase the amount of the approved budget if an award is made
for less than the amount anticipated and is inadequate to cover the pre-award
costs incurred. NIH expects the grantee to be fully aware that pre-award costs
result in borrowing against future support and that such borrowing must not
impair the grantee's ability to accomplish the project objectives in the
approved time frame or in any way adversely affect the conduct of the project.
See NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part6.htm.
6. Other Submission Requirements and Information
Applications must be prepared as described by the PHS 398 research
grant application instructions for individual research career development
(K-series) awards and include the following information:
DEVELOPMENT AWARD
Candidate:
Career Development Plan:
Research Plan:
Mentor(s)/Consultants(s)/Collaborator(s):
Environmental and institutional commitment to the candidate: The sponsoring institution must define and document a strong, well-established research and career development program related to the candidate's area of interest, including a high-quality research environment with staff capable of productive collaboration with the candidate. The sponsoring institution must provide a statement of commitment to the candidate's development into a productive, independent investigator and to meeting the requirements of this award. It should be clear that the institutional commitment to the candidate is not contingent upon receipt of the K07. In addition, the statement should:
Letters of Reference: Include with the application three sealed letters of reference from well-established scientists addressing the above areas and any other evidence that the candidate has a high potential for becoming an independent investigator. The mentor(s) may not submit letters of reference because a mentor’s statement is required as part of the application. Revised applications must include new letters of reference. A single copy of all sealed letters of reference should be attached to the face page of the application. Applications submitted without the required number of reference letters will be considered incomplete and the application will not be reviewed. Information for reference submissions is included in the application instructions.
LEADERSHIP AWARD
Overall:
Candidate:
Career Development Plan:
Curriculum Development Plan:
Environment and Institutional Commitment:
Collaborator's Statement (s): PD/PIs must include information about any collaborator(s) including her/his research and training qualifications. The application must also include information describing the nature and extent of collaboration that will occur during the proposed award period.
ALL APPLICATIONS
Training in the Responsible Conduct of Research: All applications must include a description of a program to receive formal or informal instruction in scientific integrity or the responsible conduct of research. Applications without plans for instructions in the responsible conduct of research will be considered incomplete and may be returned to the applicant without review. Although the NIH does not establish specific curricula or formal requirements, all programs are encouraged to consider instruction in the following areas: conflict of interest, responsible authorship, policies for handling misconduct, policies regarding the use of human and animal subjects, and data management. Applicants must follow the application instructions found in the PHS-398 application package and refer to the NIH web site (http://www.nih.gov/sigs/bioethics/researchethics.html) for additional guidance.
Document prior instruction in or propose plans for instruction in the responsible conduct of research in terms of subject matter and duration of instruction. An award cannot be made if the application lacks this component.
Budget: The budget request must be provided according to the instructions in form PHS 398 following information included in this FOA (Table for IC contact information). The request for research support costs, including any tuition and fees, travel, etc., must be justified and specified by category.
Appendix materials:. All paper PHS 398 applications submitted for the May 25, 2008 and subsequent due dates must provide appendix material on CD only, and include five identical CDs in the same package with the application. Paper applications submitted for due dates prior to May 25, 2008 may voluntarily provide the appendix on five identical CDs; if submitting CDs it is not necessary to include a paper appendix (see: NOT-OD-08-031).
Do not use appendix to circumvent the page limitations of the Research Plan. An application that does not observe the relevant policies and procedures may be delayed in the review process or considered as non-responsive
Resource Sharing Plan(s)
NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value of, and advance, research. When resources have been developed with NIH funds and the associated research findings published or provided to NIH, it is important that they be made readily available for research purposes to qualified individuals within the scientific community. If the final data/resources are not amenable to sharing, this must be explained in Resource Sharing section of the application. See http://grants.nih.gov/grants/policy/data_sharing/data_sharing_faqs.htm.
(a) Data Sharing Plan: Not applicable.
(b) Sharing Model Organisms: Regardless of the amount requested, all applications where the development of model organisms is anticipated are expected to include a description of a specific plan for sharing and distributing unique model organisms and related resources, or state appropriate reasons why such sharing is restricted or not possible. See Sharing Model Organisms Policy, and NIH Guide NOT-OD-04-042.
(c) Genome-Wide Association Studies (GWAS): Regardless of the amount requested, applicants seeking funding for a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or provide an appropriate explanation why submission to the repository is not possible. A genome-wide association study is defined as any study of genetic variation across the entire genome that is designed to identify genetic associations with observable traits (such as blood pressure or weight) or the presence or absence of a disease or condition. For further information see Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088, and http://grants.nih.gov/grants/gwas/.
Section V. Application Review Information
1. Criteria (Update: Enhanced review criteria have been issued for the evaluation of research applications received for potential FY2010 funding and thereafter - see NOT-OD-09-025).
Only the review criteria described
below will be considered in the review process.
2. Review and Selection Process
Applications submitted for this funding opportunity will be assigned on the basis of established PHS referral guidelines to the ICs for funding consideration. Incomplete applications will not be reviewed.
Appropriate
scientific review groups convened in accordance with the standard NIH peer
review procedures (http://www.csr.nih.gov/refrev.htm)
will evaluate applications for scientific and technical merit.
As part of the initial merit review, all applications:
Applications will compete for available funds with all other approved K07 applications. The following will be considered in making funding decisions:
The scientific review group will focus on the candidate, the mentor (for Development award), the sponsoring institutional environment and commitment, the career development plan (and curriculum development plan for the Leadership Award) and research plans, including the plans for training in the responsible conduct of research, assigning the application’s overall score, weighting them as appropriate for each application.
Candidate:
Letters of Reference/Recommendation (for Development award only):
Career/Curriculum Development Plan:
A. Development Award (Career Development Plan):
B. Leadership Award (Curriculum Development Plan):
Research Plan:
Mentoring Plan (for Development award only):
Environment and Institutional Commitment:
Training in the Responsible Conduct of Research:
2.A. Additional Review Criteria:
In addition to the above criteria, the following items
will continue to be considered in the determination of scientific merit and the
priority score:
Resubmission Applications: Are the responses to comments from the previous
scientific review group adequate? Are the improvements in the resubmission
application appropriate?
Protection of Human Subjects from Research Risk: The involvement of human
subjects and protections from research risk relating to their participation in
the proposed research will be assessed (see the Research Plan information
regarding Human Subjects in the PHS Form 398).
Inclusion of Women, Minorities and
Children in Research: The adequacy of
plans to include subjects from both genders, all racial and ethnic groups (and
subgroups), and children as appropriate for the scientific goals of the
research will be assessed. Plans for the recruitment and retention of subjects
will also be evaluated (see the Research Plan information regarding Human Subjects
in the PHS Form 398).
Care and Use of Vertebrate Animals in
Research: If vertebrate animals are to
be used in the project, the five items described in the PHS Form 398 research
grant application instructions will be assessed.
Biohazards: If materials or procedures are proposed that are
potentially hazardous to research personnel and/or the environment, determine
if the proposed protection is adequate.
2.B. Additional
Review Considerations
Budget: The
reasonableness of the proposed budget and the requested period of support in
relation to the proposed curriculum development academic award program. The
priority score should not be affected by the evaluation of the budget.
2.C. Resource Sharing Plan(s)
When relevant, reviewers will be instructed to comment on the reasonableness of the following Resource Sharing Plans, or the rationale for not sharing the following types of resources. However, reviewers will not factor the proposed resource sharing plan(s) into the determination of scientific merit or priority score, unless noted otherwise in the FOA. Program staff within the IC will be responsible for monitoring the resource sharing.
3. Anticipated Announcement and Award Dates
Not applicable
Section VI. Award
Administration Information
1. Award Notices
After the peer review of the application is completed,
the PD/PI will be able to access his or her Summary Statement (written
critique) via the eRA Commons.
If the application is under consideration for funding,
NIH will request "just-in-time" information from the applicant. For
details, applicants may refer to the NIH Grants Policy Statement Part II: Terms
and Conditions of NIH Grant Awards, Subpart A: General (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_part4.htm).
Selection of an application for award is not an
authorization to begin performance. Any costs incurred before receipt of the
Notice of Award (NoA) are at the recipient's risk. These costs may be reimbursed
only to the extent considered allowable pre-award costs. See Also Section
IV.5. Funding Restrictions.
A formal notification in the form of a NoA will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official (designated on the Application Face Page). If a grantee is not email enabled, a hard copy of the NoA will be mailed to the business official.
2. Administrative and National
Policy Requirements
All NIH grant and cooperative agreement awards include
the NIH Grants Policy Statement as part of the NoA. For these terms of award,
see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant
Awards, Subpart A: General (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part4.htm)
and Part II Terms and Conditions of NIH Grant Awards, Subpart B: Terms and
Conditions for Specific Types of Grants, Grantees, and Activities (http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_part9.htm).
The following related administrative policies apply to
NIH Research Career Award ( K ) programs:
A. Evaluation: In carrying out its stewardship of human resource-related programs, the NIH may begin requesting information essential to an assessment of the effectiveness of this program. Accordingly, recipients are hereby notified that they may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.
B. Other Income: Awardees may retain royalties and fees for activities such as scholarly writing, service on advisory groups, honoraria from other institutions for lectures or seminars, fees resulting from clinical practice, professional consultation or other comparable activities, provided these activities remain incidental, are not required by the research and research-related activities of this award, and provided that the retention of such pay is consistent with the policies and practices of the grantee institution.
All other income and fees, not included in the preceding paragraph as retainable, may not be retained by the career award recipient. Such fees must be assigned to the grantee institution for disposition by any of the following methods:
Usually, funds budgeted in an NIH supported research grant for the salaries or fringe benefits of individuals, but freed as a result of a career award, may not be rebudgeted. The awarding component will give consideration to approval for the use of released funds only under unusual circumstances. Any proposed retention of funds released as a result of a career award must receive prior written approval of the NIH awarding component.
C. Special Leave: Leave to another institution, including a foreign laboratory, may be permitted if the proposed experience is directly related to the purpose of the award. Only local institutional approval is required if such leave does not exceed 3 months. For longer periods, prior written approval of the NIH awarding component is required and will be granted only in unusual situations. Details on the process for submission of prior approval requests can be founds in the NIH Grants Policy Statement, Requests for Prior Approval, at http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part7.htm#_Toc54600130.) The request must include the reasons for the leave and a description of the provisions that will be made to ensure that the awardee will be able to continue meeting the requirements of this award during the period of the leave. A copy of a letter or other evidence from the institution where the leave is to be taken also must be submitted to assure that satisfactory arrangements have been made. If the request is approved, support from the K07 award will continue during such leave.
Leave without award support may not exceed 12 months. Such leave requires the prior written approval of the NIH awarding component and will be granted only in unusual situations. Support from other sources is permissible during the period of leave. Such leave does not reduce the total number of months of program support for which an individual is eligible.
Under unusual and pressing circumstances the Development awardee may submit a written request to the awarding component requesting a reduction in professional effort below 75% (9 person months). Such requests will be considered on a case-by-case basis consistent with the policies of the NIH awarding component. The nature of the circumstances requiring reduced effort might include medical conditions, disability, or pressing personal or family situations such as child or elder care. Permission to reduce effort will not be approved to accommodate job opportunities, clinical practice, or clinical training. In each situation, the grantee institution must submit documentation supporting the need for reduced effort along with assurance of a continuing commitment to the scientific development of the awardee. In addition, the awardee must submit assurance of his/her intention to return to the required effort at least 9 person months (at least 75%) as soon as possible. During the period of reduced effort, the salary and other costs supported by the award will be reduced accordingly.
D. Changes in the K07 plans: Individual awards are made for career development at a specific institution in a specific research program. Consultation with the applicable Institute program staff is required when a change in the curriculum development or research activities approved for the academic award that is being conducted under the K07 award is being considered.
A scientific rationale must be provided for any proposed changes in the aims of the original peer-reviewed academic award plan. Supporting justification for any proposed change will be evaluated by Institute program staff to ensure that these components remain within the scope of the original peer-reviewed program. The impact of the proposed changes as they relate to the academic career development of the candidate or the enhancement of a curriculum development program at the sponsoring institution will be assessed. If the proposed new activities are inconsistent with the goals and objectives of the K07 program, program staff could recommend that the award be terminated.
E. Mentor change: In rare cases where a mentor must be replaced for the recipient of the Development awardee, the institution must submit a letter from the proposed mentor and awardee documenting the need for substitution, the new mentor’s qualifications for supervising the program, and the level of support for the awardee’s continued career development. The letter must also document that the specific aims of the academic and research program will remain within the scope of the original peer reviewed program. NIH staff will evaluate the request and will notify the institution of the results of the evaluation.
F. Change of Institution or Termination: The objectives of the K07 Leadership award are to increase the pool of individuals involved in curriculum development and to enhance existing curriculum development programs within the sponsoring institution. A Leadership award requires that the sponsoring institution make a clear commitment to the awardee. Consequently, a Leadership award is not transferable to another institution.
A K07 Development award can be transferred to another institution with prior approval of program staff of the supporting NIH institute. A change of institution normally will be permitted only when all of the benefits attributable to the original grant can be transferred, including equipment purchased in whole or in part with grant funds. In reviewing a request to transfer a grant, NIH will consider whether there is a continued need for the grant-supported project or activity and the impact of any proposed changes in the scope of the project, and the qualifications of the proposed new mentor. A change may be made without peer review, provided the PI plans no significant change in research and career development objectives and the facilities and resources at the new organization will allow for successful performance of the project. If these conditions or other programmatic or administrative requirements are not met, the NIH awarding office may require peer review or may disapprove the request and, if appropriate, terminate the award.
If the PD/PI is moving to another eligible institution, K07 Development award support may be continued provided:
When a grantee institution plans to terminate an award (Leadership or Development), the Grants Management Specialist listed on the NoA must be notified in writing at the earliest possible time so that appropriate instructions ca be provided for termination. The Director of the NIH may discontinue an award upon determination that the purpose or terms of the award are not being fulfilled. In the event an award is terminated, the NIH Director shall notify the grantee institution and career award recipient in writing of this determination, the reasons therefore, the effective date, and the right to appeal the decision.
3. Reporting
Awardees will be required to submit the PHS Non-Competing Grant Progress
Report, Form 2590, annually. Note that the instructions for Research
Career Development applications must be followed for this program.
http://grants.nih.gov/grants/funding/2590/2590.htm and financial statements as required in the NIH Grants Policy Statement.
The Progress Report must include information requested in the general PHS form 2590 instructions, as well as information requested in the Research Career Development Section of the 2590 instructions. Evaluation of the awardee s progress will encompass the following:
A final progress report, invention statement, and Financial Status Report are required when an award is relinquished, when a recipient changes institutions, or when an award is terminated.
We encourage your inquiries concerning this funding
opportunity and welcome the opportunity to answer questions from potential
applicants. Inquiries may fall into three areas: scientific/research, peer
review, and financial or grants management issues:
1.
Scientific/Research Contacts:
Applicant should refer to the NIH Web site (Table for IC contact information) for information regarding each IC s
scientific/research contacts for this K07 program.
2. Peer Review Contacts:
Not applicable.
3. Financial or Grants Management Contacts:
Applicants should refer to the NIH Web site (Table for IC contact information) for information regarding each IC's Grants Management contact for this K07 program.
Section VIII. Other Information
Required Federal Citations
Use
of Animals in Research:
Recipients of PHS support for activities involving
live, vertebrate animals must comply with PHS Policy on Humane Care and Use of
Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf),
as mandated by the Health Research Extension Act of 1985 (http://grants.nih.gov/grants/olaw/references/hrea1985.htm),
and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm),
as applicable.
Human Subjects Protection:
Federal regulations (45CFR46) require that
applications and proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of protection against
these risks, the potential benefits of the research to the subjects and others,
and the importance of the knowledge gained or to be gained. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm.
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types
of clinical trials, including physiologic toxicity, and dose-finding studies
(phase I); efficacy studies (Phase II) efficacy, effectiveness and comparative
trials (Phase III). Monitoring should be commensurate with risk. The
establishment of data and safety monitoring boards (DSMBs) is required for
multi-site clinical trials involving interventions that entail potential risks to
the participants. (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, June 12, 1998: http://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking
$500,000 or more in direct costs in any single year are expected to include a
plan for data sharing or state why this is not possible. http://grants.nih.gov/grants/policy/data_sharing
Investigators should seek guidance from their
institutions, on issues related to institutional policies, local IRB rules, as
well as local, State and Federal laws and regulations, including the Privacy
Rule. Reviewers will consider the data sharing plan but will not factor the
plan into the determination of the scientific merit or the priority score.
Policy for Genome-Wide
Association Studies (GWAS):
NIH is interested in advancing
genome-wide association studies (GWAS) to identify common genetic factors that
influence health and disease through a centralized GWAS data repository. For
the purposes of this policy, a genome-wide association study is defined as any
study of genetic variation across the entire human genome that is designed to
identify genetic associations with observable traits (such as blood pressure or
weight), or the presence or absence of a disease or condition. All
applications, regardless of the amount requested, proposing a genome-wide
association study are expected to provide a plan for submission of GWAS data to
the NIH-designated GWAS data repository, or provide an appropriate explanation
why submission to the repository is not possible. Data repository management (submission
and access) is governed by the Policy for Sharing of Data Obtained in NIH
Supported or Conducted Genome-Wide Association Studies, NIH Guide
NOT-OD-07-088. For additional information, see http://grants.nih.gov/grants/gwas/.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage
sharing of important research resources including the sharing of model
organisms for biomedical research (see http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-04-042.html).
At the same time the NIH recognizes the rights of grantees and contractors to
elect and retain title to subject inventions developed with Federal funding
pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm).
All investigators submitting an NIH application or contract proposal beginning
with the October 1, 2004 receipt date, are expected to include in the
application/proposal a description of a specific plan for sharing and
distributing unique model organism research resources generated using NIH funding
or state why such sharing is restricted or not possible. This will permit other
researchers to benefit from the resources developed with public funding. The
inclusion of a model organism sharing plan is not subject to a cost threshold
in any year and is expected to be included in all applications where the
development of model organisms is anticipated.
Access to Research Data through the Freedom of
Information Act:
The Office of Management and Budget (OMB) Circular
A-110 has been revised to provide public access to research data through the
Freedom of Information Act (FOIA) under some circumstances. Data that are (1)
first produced in a project that is supported in whole or in part with Federal
funds and (2) cited publicly and officially by a Federal agency in support of
an action that has the force and effect of law (i.e., a regulation) may be
accessed through FOIA. It is important for applicants to understand the basic
scope of this amendment. NIH has provided guidance at http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this funding opportunity in a
public archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the application. In
addition, applicants should think about how to structure informed consent
statements and other human subjects procedures given the potential for wider
use of data collected under this award.
Inclusion of Women And Minorities in Clinical Research:
It is the policy of the NIH that women and members of
minority groups and their sub-populations must be included in all NIH-supported
clinical research projects unless a clear and compelling justification is
provided indicating that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research. This policy results from the
NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All
investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html);
a complete copy of the updated Guidelines is available at http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of clinical
research; updated racial and ethnic categories in compliance with the new OMB
standards; clarification of language governing NIH-defined Phase III clinical
trials consistent with the new PHS Form 398; and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: a) all
applications or proposals and/or protocols must provide a description of plans
to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable; and b)
investigators must report annual accrual and progress in conducting analyses,
as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical Research:
The NIH maintains a policy that children (i.e.,
individuals under the age of 21) must be included in all clinical research,
conducted or supported by the NIH, unless there are scientific and ethical
reasons not to include them.
All investigators proposing research involving human
subjects should read the "NIH Policy and Guidelines" on the inclusion
of children as participants in research involving human subjects that is
available at http://grants.nih.gov/grants/funding/children/children.htm.
Required Education on The Protection of Human Subject Participants:
NIH policy requires education on the protection of
human subject participants for all investigators submitting NIH applications
for research involving human subjects and individuals designated as key
personnel. The policy is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can
be found at http://grants.nih.gov/grants/stem_cells.htm and at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html.
Only research using hESC lines that are registered in the NIH Human Embryonic
Stem Cell Registry will be eligible for Federal funding (see http://escr.nih.gov/). It is the responsibility
of the applicant to provide the official NIH identifier(s) for the hESC line(s)
to be used in the proposed research. Applications that do not provide
this information will be returned without review.
NIH Public Access Policy Requirement:
In accordance with the NIH Public Access Policy (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-033.html),
investigators must submit or have submitted for them their final, peer-reviewed
manuscripts that arise from NIH funds and are accepted for publication as of
April 7, 2008 to PubMed Central (http://www.pubmedcentral.nih.gov/), to be made
publicly available no later than 12 months after publication. As of May 27,
2008, investigators must include the PubMed Central reference number when
citing an article in NIH applications, proposals, and progress reports that
fall under the policy, and was authored or co-authored by the investigator or
arose from the investigator’s NIH award. For more information, see the Public
Access webpage at http://publicaccess.nih.gov/.
Standards for Privacy of Individually Identifiable
Health Information:
The Department of Health and Human Services (DHHS)
issued final modification to the "Standards for Privacy of Individually
Identifiable Health Information", the "Privacy Rule," on August
14, 2002. The Privacy Rule is a federal regulation under the Health
Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the
protection of individually identifiable health information, and is administered
and enforced by the DHHS Office for Civil Rights (OCR). Those who must comply
with the Privacy Rule (classified under the Rule as "covered
entities") must do so by April 14, 2003 (with the exception of small
health plans which have an extra year to comply).
Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website (http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grants Applications or Appendices:
All applications and proposals for NIH funding must be
self-contained within specified page limitations. For publications listed in
the appendix and/or Progress report, internet addresses (URLs) must be
used for publicly accessible on-line journal articles. Unless
otherwise specified in this solicitation, Internet addresses (URLs)
should not be used to provide any other information necessary for
the review because reviewers are under no obligation to view the Internet
sites. Furthermore, we caution reviewers that their anonymity may be
compromised when they directly access an Internet site.
Health People 2010:
The Public Health Service (PHS) is committed to
achieving the health promotion and disease prevention objectives of
"Healthy People 2010," a PHS-led national activity for setting
priority areas. This PA is related to one or more of the priority areas.
Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is described in the Catalog of Federal
Domestic Assistance No. 93.398 at http://www.cfda.gov/,
and is not subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency review. Awards are made under
authorization of Sections 301 and 405 of the Public Health Service Act as
amended (42 USC 241and 284) and administered under NIH grants policies
described at http://grants.nih.gov/grants/policy/policy.htm and under Federal
Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are subject to
the terms and conditions, cost principles, and other considerations described
in the NIH Grants Policy Statement. The NIH Grants Policy Statement can be
found at http://grants.nih.gov/grants/policy/policy.htm.
The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Loan Repayment Programs:
Please note that NIH encourages applications for
educational loan repayment from qualified health professionals who have made a
commitment to pursue a research career involving clinical, pediatric,
contraception, infertility, and health disparities related areas. The
Loan Repayment Program (LRP) is an important component of NIH’s efforts to
recruit and retain the next generation of researchers by providing the means
for developing a research career unfettered by the burden of student loan
debt. Note that an NIH grant is not required for eligibility and
concurrent career award and LRP applications are encouraged. The periods
of career award and LRP award may overlap providing the LRP recipient with the
required commitment of time and effort, because LRP awardees must commit at
least 50% of their time (at least 20 hours per week based on a 40 hour week)
for two years to research. For further information, please see: http://www.lrp.nih.gov/
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||